Taichi Kuramochi

Head of Biologics Discovery Department at Chugai Pharmaceutical Co., Ltd.

Speaker

I am the Head of the Biologics Discovery Department at Chugai Pharmaceutical, where I have been working for over 20 years since graduating from university. My research focuses on developing innovative antibody technologies, including Recycling Antibody®, Sweeping Antibody®, and Switch-Ig™. These novel platforms have significantly enhanced the efficacy and safety of antibody therapeutics.

My work has led to several breakthroughs in the field of antibody engineering, resulting in multiple patents and high-impact publications. In this presentation, I will introduce next-generation T cell engagers utilizing the Dual-Ig® technology, furthering the field of targeted cancer immunotherapy.